Targeting polo-like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinoma
Background Adrenocortical carcinoma (ACC) is an aggressive cancer with a 5 year survival
rate of 20–30%. Various factors have been implicated in the pathogenesis of ACC including …
rate of 20–30%. Various factors have been implicated in the pathogenesis of ACC including …
Clinical score predicting long-term survival after repeat resection for recurrent adrenocortical carcinoma
Background Adrenocortical carcinoma (ACC) is an aggressive malignancy typically resistant
to chemotherapy and radiation. Surgery, even in the setting of locally recurrent or metastatic …
to chemotherapy and radiation. Surgery, even in the setting of locally recurrent or metastatic …
Incidence of perioperative complications following resection of adrenocortical carcinoma and its association with long‐term survival
Background The association of postoperative complications with long‐term oncologic
outcomes remains unclear. We sought to determine the incidence of complications among …
outcomes remains unclear. We sought to determine the incidence of complications among …
Adrenocortical carcinoma: modern management and evolving treatment strategies
LA McDuffie, RD Aufforth - International journal of endocrine …, 2016 - Taylor & Francis
Adrenocortical carcinoma (ACC) is a rare cancer with a poor prognosis. Unlike many other
cancers, there has been little improvement in patient outcome over the past several …
cancers, there has been little improvement in patient outcome over the past several …
Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using 18F-FDG positron emission tomography
As an orphan malignancy, only limited treatment options are available in adrenocortical
carcinoma (ACC). Non-invasive risk assessment has not been described but may be of …
carcinoma (ACC). Non-invasive risk assessment has not been described but may be of …
Tumours of the Adrenal Gland
V Palter, K Devon, J Hallet, GS Kulkarni… - Surgical Oncology …, 2016 - Springer
Tumours of the adrenal gland are very common. They can be functional or non-functional,
benign or malignant or arise in the adrenal cortex or medulla. The majority of adrenal …
benign or malignant or arise in the adrenal cortex or medulla. The majority of adrenal …
Адренокортикален карцином, асоцииран с белодробна тромбоемболия–литературен обзор и клиничен случай
Ж Грудева-Попова, В Попов, Е Белева… - Редки болести и …, 2016 - journal.raredis.org
Въведение: Адренокортикалният карцином е изключително рядък тумор. Честотата му
варира около 0.6-1.67 случая на 1 000 000 население. Съществува полова …
варира около 0.6-1.67 случая на 1 000 000 население. Съществува полова …
[PDF][PDF] Recurrence and mortality in adulthood adrenocortical tumors: analysis from the Brazilian National Institute of Cancer experience
D Bulzico, PA Faria, MP De Paula… - Cancer Res …, 2016 - pdfs.semanticscholar.org
Introduction: While adrenocortical adenomas (ACA) are usually of indolent course,
carcinomas (ACC) are very aggressive, extremely rare and harbor a poor prognosis. This …
carcinomas (ACC) are very aggressive, extremely rare and harbor a poor prognosis. This …